Welcome! If you’re a new visitor, you may want to subscribe to our RSS feed. Thanks for visiting!Let’s face it.  Stocking up on drugs is not an idea that makes your insurance company happy.  But the challenge of having the right drugs on hand at the right time is adding to worldwide migraine […]

Popularity: 66% [?]

Back in early 2006 I wrote about a new class of migraine drugs that was in the testing phases.  It’s called a gap junction blocker, and the drug being tested is called tonabersat.  It’s time for an update!
A major phase of the clinical trials have been completed for tonabersat.  The results were encouraging, and reason […]

Popularity: 86% [?]

Last month a new option was made available to people with migraine in Canada.  That option is another triptan drug - frovatriptan succinate, to be exact, or Frova.
Frova has had its ups and downs.  It has showed some promise particularly for menstrually related migraine.  It was heavily promoted (in a round about way) for menstrual […]

Popularity: 51% [?]

In a recent article, Dr Brent Bauer (director of the Complementary and Integrative Medicine Program at the Mayo Clinic) noted that more and more supplements are being marketed to target specific health problems.  As you know, it’s not just supplements, but the mainstream painkillers as well.  Is this good or bad?
Well, it’s helpful to target […]

Popularity: 73% [?]

Novartis is the company, and Excedrin Tension Headache is the brand.  More and more often, companies are trying to market to specific kinds of headaches and pain.  Novartis has also recently come out with Excedrin Back & Body, for example.  Older products such as Quick Tabs Peppermint, marketed more as a general headache treatment, have […]

Popularity: 15% [?]

Pregabalin, sold as Lyrica, is a relatively new drug.  It was approved in the EU in 2004, and in the US in 2005.  Pregabalin has been used to treat nerve pain, such as diabetic nerve pain and pain after shingles.  It has also been used to treat partial onset seizures.
But pregabalin has been popping up […]

Popularity: 14% [?]

You might have heard about Pozen’s migraine product, Trexima, which is currently under review in the USA.  I know I’ve heard about it - a lot about it.  I’ve written about Trexima before, more than once.
Trexima is a combination drug.  Its key ingredients are sumatriptan succinate (otherwise known as Imitrex) and naproxen sodium.  Both of […]

Popularity: 12% [?]